Huang-Lian-Jie-Du decoction alleviates diabetic ischemic stroke by modulating gut microbiota-derived short-chain fatty acids
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Chong Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medicine School, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China; Key Laboratory of Digital…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drugs, Chinese Herbal, Fatty Acids, Volatile, Ischemic Stroke. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Department of Education of Guangdong Province, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Diabetic Ischemic Stroke (DIS) is a devastating complication of diabetes, associated with high morbidity and mortality. Huang-Lian-Jie-Du Decoction (HLJDD), a renowned traditional Chinese medicine prescription, has demonstrated diverse pharmacological activities, including ameliorating diabetes, neurological disorders, and intestinal dysbiosis. However, the therapeutic effects of HLJDD and its underlying mechanisms against DIS remain elusive. PURPOSE: To investigate the therapeutic effects of HLJDD on DIS and explore its underlying mechanisms, focusing on gut microbiota-derived short-chain fatty acids (SCFAs) and the TLR4/NF-κB pathway. METHODS: A DIS rat model was established using high-fat diet (HFD) and streptozotocin (STZ), followed by middle cerebral artery occlusion/reperfusion (MCAO/R). Rats were treated with HLJDD or SCFAs. Neurological function, infarct size, lipid metabolism, inflammation, and gut microbiota were assessed. 16S rDNA sequencing, GC-MS, RT-qPCR, and Western blotting were used to analyze SCFAs, microbiota composition, and TLR4/NF-κB pathway. A pseudo-germ-free (PGF) model validated microbiota dependency. RESULTS: HLJDD reduced cerebral infarct size, improved neurological deficits, and alleviated dyslipidemia and nitrative stress. It restored gut microbiota balance, increased SCFAs, and enhanced intestinal barrier integrity. HLJDD inhibited TLR4/NF-κB pathway activation in the gut-brain axis, reducing systemic and neuroinflammation. SCFAs administration replicated these benefits, while microbiota depletion diminished HLJDD's efficacy. CONCLUSIONS: Our findings provide the first evidence that HLJDD alleviates DIS by modulating the gut-brain axis via enhancement of microbiota-derived SCFAs and inhibition of TLR4/NF-κB pathway, highlighting its potential as a novel therapeutic strategy for DIS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medicine School, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China; Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica of State Administration…
- The First Clinical Medicine School, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China; Guangdong Yifang Pharmaceutical Co.,Ltd, Foshan, China.
- Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica of State Administration of TCM and Engineering Technology Research Center for Chinese Materia Medica Quality of Guangdong Province, Guangdong Pharma…
- State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Nanchang, China.
- The First Clinical Medicine School, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China; State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Med…
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Department of Education of Guangdong Province
- National Natural Science Foundation of China
- State Key Laboratory of Fire Science
Zitieren
APA
Chen, C., Luo, W. H., Li, A., Wu, H. Z., Chen, D. Y., Chen, J. X., Wang, Z. Q., Wang, S. M., & Tang, D. (2025). Huang-Lian-Jie-Du decoction alleviates diabetic ischemic stroke by modulating gut microbiota-derived short-chain fatty acids. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157476
Vancouver
Chen C, Luo WH, Li A, Wu HZ, Chen DY, Chen JX, et al. Huang-Lian-Jie-Du decoction alleviates diabetic ischemic stroke by modulating gut microbiota-derived short-chain fatty acids. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157476
BibTeX
@article{Chen2025,
author = {Chen, Chong and Luo, Wen-Hui and Li, Ao and Wu, Hua-Ze and Chen, Die-Yi and Chen, Jie-Xin and Wang, Zhi-Quan and Wang, Shu-Mei and Tang, Dan},
title = {Huang-Lian-Jie-Du decoction alleviates diabetic ischemic stroke by modulating gut microbiota-derived short-chain fatty acids},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157476}
}
EUVIMED